다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The Korean journal of internal medicine : KJIM, v.33 no.2, 2018년, pp.367 - 382
Cha, Jin Joo (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Min, Hye Sook (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Kim, Kitae (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Lee, Mi Jin (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Lee, Mi Hwa (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Kim, Jung Eun (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Song, Hye Kyoung (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Cha, Dae Ryong (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea) , Kang, Young Sun (Department of Nephrology, Korea University Ansan Hospital, Ansan, Korea)
AI-Helper
Background/AimsRecent studies have suggested an important role of adipokines in the development of insulin resistance and diabetes mellitus. The clinical relevance of adipokines on long-term outcomes in patients with diabetes and chronic kidney disease is uncertain. The purpose of this study was to ...
1 Pradhan AD Manson JE Rifai N Buring JE Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 2001 286 327 334 11466099
2 Devaraj S Glaser N Griffen S Wang-Polagruto J Miguelino E Jialal I Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes Diabetes 2006 55 774 779 16505242
3 Lafontan M Adipose tissue and adipocyte dysregulation Diabetes Metab 2014 40 16 28 24139247
4 Romacho T Elsen M Rohrborn D Eckel J Adipose tissue and its role in organ crosstalk Acta Physiol (Oxf ) 2014 210 733 753 24495317
5 Mills KT Hamm LL Alper AB Circulating adipocytokines and chronic kidney disease PLoS One 2013 8 e76902 24116180
6 Adamczak M Chudek J Wiecek A Adiponectin in patients with chronic kidney disease Semin Dial 2009 22 391 395 19708988
7 Briffa JF McAinch AJ Poronnik P Hryciw DH Adipokines as a link between obesity and chronic kidney disease Am J Physiol Renal Physiol 2013 305 F1629 F1636 24107418
8 Min HS Kim JE Lee MH Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet Kidney Res Clin Pract 2014 33 33 44 26877948
9 Deng Y Scherer PE Adipokines as novel biomarkers and regulators of the metabolic syndrome Ann N Y Acad Sci 2010 1212 E1 E19
10 Cha JJ Hyun YY Jee YH Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway Kidney Res Clin Pract 2012 31 177 185 26894024
11 Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 1998 15 539 553 9686693
12 Chamberlain JJ Rhinehart AS Shaefer CF Jr Neuman A Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes Ann Intern Med 2016 164 542 552 26928912
13 Tuttle KR Bakris GL Bilous RW Diabetic kidney disease: a report from an ADA Consensus Conference Am J Kidney Dis 2014 64 510 533 25257325
14 Guo X Zhou G Guo M Cheung AK Huang Y Beddhu S Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II Physiol Rep 2014 2 e00230 24744899
15 Jorsal A Tarnow L Frystyk J Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy Kidney Int 2008 74 649 654 18496510
16 Menon V Li L Wang X Adiponectin and mortality in patients with chronic kidney disease J Am Soc Nephrol 2006 17 2599 2606 16885405
17 Looker HC Krakoff J Funahashi T Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes J Clin Endocrinol Metab 2004 89 4010 4017 15292342
18 Martinez Cantarin MP Keith SW Waldman SA Falkner B Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease Nephrol Dial Transplant 2014 29 2268 2277 25049200
19 Guebre-Egziabher F Bernhard J Funahashi T Hadj-Aissa A Fouque D Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function Nephrol Dial Transplant 2005 20 129 134 15585515
20 Martinez Cantarin MP Waldman SA Doria C The adipose tissue production of adiponectin is increased in end-stage renal disease Kidney Int 2013 83 487 494 23283133
21 Herder C Bongaerts BW Rathmann W Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study Diabetes Care 2015 38 91 96 25325880
22 Ussar S Bezy O Bluher M Kahn CR Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine Diabetes 2012 61 2289 2298 22751693
23 Yoo HJ Hwang SY Cho GJ Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease J Clin Endocrinol Metab 2013 98 2897 2901 23633195
24 Watanabe K Yamada H Yamaguchi Y K-glypican: a novel GPI-anchored heparin sulfate proteoglycan that is highly expressed in developing brain and kidney J Cell Biol 1995 130 1207 1218 7657705
25 Strate I Tessadori F Bakkers J Glypican4 promotes cardiac specification and differentiation by attenuating canonical Wnt and Bmp signaling Development 2015 142 1767 1776 25968312
26 Chang GY Park AS Susztak K Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease Kidney Int 2011 79 802 804 21451535
27 Hirakawa Y Arima H Zoungas S Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial Diabetes Care 2014 37 2359 2365 24812434
28 Muggeo M Zoppini G Bonora E Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study Diabetes Care 2000 23 45 50 10857967
29 Ceriello A Esposito K Piconi L Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients Diabetes 2008 57 1349 1354 18299315
30 Wu J Bostrom P Sparks LM Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human Cell 2012 150 366 376 22796012
31 Roca-Rivada A Castelao C Senin LL FNDC5/irisin is not only a myokine but also an adipokine PLoS One 2013 8 e60563 23593248
32 Liu JJ Wong MD Toy WC Lower circulating irisin is associated with type 2 diabetes mellitus J Diabetes Complications 2013 27 365 369 23619195
33 Liu JJ Liu S Wong MD Relationship between circulating irisin, renal function and body composition in type 2 diabetes J Diabetes Complications 2014 28 208 213 24332937
34 Li DJ Huang F Lu WJ Jiang GJ Deng YP Shen FM Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation Acta Physiol (Oxf ) 2015 213 711 721 25382002
35 Moschen AR Kaser A Enrich B Visfatin, an adipocytokine with proinflammatory and immunomodulating properties J Immunol 2007 178 1748 1758 17237424
36 Kang YS Cha DR The role of visfatin in diabetic nephropathy Chonnam Med J 2011 47 139 143 22247912
37 Vikram NK Misra A Pandey RM Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes: receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard Diabetes Nutr Metab 2003 16 32 40 12848303
38 Kollerits B Fliser D Heid IM Ritz E Kronenberg F MMKD Study Group Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study Kidney Int 2007 71 1279 1286 17457380
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.